U.S. markets open in 1 hour 30 minutes
  • S&P Futures

    4,150.25
    -33.25 (-0.79%)
     
  • Dow Futures

    34,534.00
    -134.00 (-0.39%)
     
  • Nasdaq Futures

    13,157.50
    -199.25 (-1.49%)
     
  • Russell 2000 Futures

    2,176.00
    -33.60 (-1.52%)
     
  • Crude Oil

    64.13
    -0.79 (-1.22%)
     
  • Gold

    1,840.20
    +2.60 (+0.14%)
     
  • Silver

    27.57
    +0.07 (+0.27%)
     
  • EUR/USD

    1.2170
    +0.0035 (+0.29%)
     
  • 10-Yr Bond

    1.6020
    0.0000 (0.00%)
     
  • Vix

    21.48
    +4.79 (+28.70%)
     
  • GBP/USD

    1.4148
    +0.0026 (+0.19%)
     
  • USD/JPY

    108.5820
    -0.2590 (-0.24%)
     
  • BTC-USD

    55,196.58
    -2,863.28 (-4.93%)
     
  • CMC Crypto 200

    1,576.62
    +15.32 (+0.98%)
     
  • FTSE 100

    6,966.80
    -156.88 (-2.20%)
     
  • Nikkei 225

    28,608.59
    -909.71 (-3.08%)
     

Reckitt Benckiser Group plc (LON:RB.) Shares Could Be 24% Above Their Intrinsic Value Estimate

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·6 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

How far off is Reckitt Benckiser Group plc (LON:RB.) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. We will use the Discounted Cash Flow (DCF) model on this occasion. There's really not all that much to it, even though it might appear quite complex.

Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.

View our latest analysis for Reckitt Benckiser Group

Crunching the numbers

We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value:

10-year free cash flow (FCF) estimate

2021

2022

2023

2024

2025

2026

2027

2028

2029

2030

Levered FCF (£, Millions)

UK£2.05b

UK£2.37b

UK£2.74b

UK£2.67b

UK£2.64b

UK£2.63b

UK£2.63b

UK£2.64b

UK£2.66b

UK£2.68b

Growth Rate Estimate Source

Analyst x10

Analyst x9

Analyst x2

Analyst x1

Est @ -1.17%

Est @ -0.46%

Est @ 0.05%

Est @ 0.4%

Est @ 0.65%

Est @ 0.82%

Present Value (£, Millions) Discounted @ 6.8%

UK£1.9k

UK£2.1k

UK£2.2k

UK£2.1k

UK£1.9k

UK£1.8k

UK£1.7k

UK£1.6k

UK£1.5k

UK£1.4k

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = UK£18b

After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.2%. We discount the terminal cash flows to today's value at a cost of equity of 6.8%.

Terminal Value (TV)= FCF2030 × (1 + g) ÷ (r – g) = UK£2.7b× (1 + 1.2%) ÷ (6.8%– 1.2%) = UK£49b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= UK£49b÷ ( 1 + 6.8%)10= UK£25b

The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is UK£44b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of UK£76.0, the company appears slightly overvalued at the time of writing. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.

dcf
dcf

The assumptions

We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Reckitt Benckiser Group as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.8%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Looking Ahead:

Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. The DCF model is not a perfect stock valuation tool. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. Can we work out why the company is trading at a premium to intrinsic value? For Reckitt Benckiser Group, we've put together three essential elements you should further examine:

  1. Risks: For example, we've discovered 2 warning signs for Reckitt Benckiser Group (1 is a bit concerning!) that you should be aware of before investing here.

  2. Future Earnings: How does RB.'s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St updates its DCF calculation for every British stock every day, so if you want to find the intrinsic value of any other stock just search here.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.